Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Cancer Science|June 17, 2005
High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal modelHiroyuki Tsuda, Katsumi Fukamachi, Yutaka Ohshima, et al.
International Journal of Clinical Oncology|January 12, 2012
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trialToshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, et al.
Anticancer Research|April 3, 2014
Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patientsYusuke Sasaki, Tetsuya Hamaguchi, Tatsuhiro Arai, et al.
Anticancer Research|August 9, 2015
Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic SignificanceHirokazu Shoji, Yasuhide Yamada, Natsuko Okita, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2009
Adipocytokines and squamous cell carcinoma of the esophagusTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2023
Bile Duct Mixed Neuroendocrine-nonendocrine Neoplasm with a Complete Response to ChemoradiotherapyYosuke Horita, Yoshiaki Mihara, Masafumi Mizuide, et al.
Cancer Science|March 25, 2010
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
Journal of Gastroenterology|May 12, 2009
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancerTakako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, et al.
BMC Gastroenterology|August 14, 2025
Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective studyTakatsugu Fujii, Masataka Hirasaki, Yasuo Kamakura, et al.
International Journal of Clinical Oncology|November 13, 2013
Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancerYoshitaka Honma, Yasuhiro Shimada, Atsuo Takashima, et al.
Pageof 22